EN
HI
Summary
As of 26 Aug, 2026, Gufic Biosciences stock price is ₹417.7. During the trading session, the stock has moved between an intraday low of ₹415.50 and an intraday high of ₹419.00. Over the last 52 weeks, Gufic Biosciences has traded between ₹268.00 and ₹448.00.
The stock has recorded a trading volume of 6,266 shares, with a market capitalization of ₹100282506. Its Average Traded Price (ATP) is ₹416.70, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 30 @ ₹417.70.
Gufic Biosciences has an upper circuit limit of ₹496.35 and a lower circuit limit of ₹330.95. The total value traded stands at ₹26.11 L, and the delivery percentage for the day is 54.9%.
The stock is currently traded with a market lot size of 1. Gufic Biosciences also offers a dividend yield of 0.02%.
Gufic Biosciences share price chart
Gufic Biosciences Share Key Metrics
Volume
6266.00
Market Cap
4148.19 CR
LTQ@LTP
30@417.70
ATP
416.7
Var Margin
18.65 %
Circuit Range
330.95-496.35
Delivery %
54.9 %
Value
26.11 L
ASM/GSM
No
Market Lot
1
Gufic Biosciences Fundamentals
P/E Ratio
56.53
P/B Ratio
6.04
Div. Yield
0.02
Sector P/E
69.27
Sector P/B
3.36
Sec. Div. Yield
0.51
Gufic Biosciences Resistance and Support
Pivot 414.1
Resistance
First Resistance
418.2
Second Resistance
422.75
Third Resistance
426.85
Support
First Support
409.55
Second Support
405.45
Third Support
400.9
Gufic Biosciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Aug 26 2026 | 417.75 | 417.7 | 0.98% | 419 | 415.5 |
| Tue Aug 25 2026 | 414.75 | 413.64 | -1.04% | 418.64 | 410 |
| Mon Aug 24 2026 | 431.95 | 418 | -3.13% | 433.04 | 411 |
Gufic Biosciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-30 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results & Others |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Gufic Biosciences News
Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Gufic BioSciences uploaded the audio recording of its earnings conference call held on August 17, 2026. Investors can access the recording via the company's website. A written transcript will be submitted shortly.
Aug 17 2026 18:31:13
Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Acquisition
Gufic BioSciences' Board approved the incorporation of a new subsidiary in the Philippines. This strategic move, involving an investment of up to USD 250,000 for a 99.99% equity stake, aims to expand the company's pharmaceutical product marketing and distribution in the region.
Aug 14 2026 20:05:21
Read More
Gufic Biosciences Management
| Name | Position |
|---|---|
| Ami Shah | Company Secretary & Compliance Officer |
| Jayesh P Choksi | Chairman & Managing Director |
Gufic Biosciences Similar Stocks
Morepen Laboratories Ltd.
95.37
1.47 (1.57%)
Artemis Medicare Services Ltd.
326.35
2.65 (0.82%)
Supriya Lifescience Ltd.
784.65
-7.00 (0.88%)
IOL Chemicals And Pharmaceuticals Ltd.
182.73
10.36 (6.01%)
RPG Life Sciences Ltd.
2585.00
0.50 (0.02%)
Aarti Drugs Ltd.
420.90
-1.30 (0.31%)
Indraprastha Medical Corporation Ltd.
371.95
-1.00 (0.27%)
Kwality Pharmaceuticals Ltd.
3358.00
-15.10 (0.45%)
Unichem Laboratories Ltd.
529.45
3.40 (0.65%)
Advanced Enzyme Technologies Ltd.
302.15
2.40 (0.80%)
Gufic Biosciences FAQs
The Buying Price of Gufic Biosciences share is 417.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Gufic Biosciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gufic Biosciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Gufic Biosciences shares is 56.53. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Gufic Biosciences shares is 6.04. Useful to assess the stock's value relative to its book value.
To assess Gufic Biosciences’s valuation compare Sector P/E, P/B which are 69.27 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Gufic Biosciences is 4148.19 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Gufic Biosciences share price is 448.00 & 268.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Gufic Biosciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
